AI has the potential to transform many aspects of care. In order for AI to reach its full potential, discussion on optimizing data should be addressed. This session will focus on tackling those hard questions.
Vice-President Research and Development - Cardiac Diagnostic and Services Business
Assistant Director - Blood Pressure and Flow Devices
Food and Drug Administration (FDA)
Senior Clinical Scientist, Philips Ambulatory Monitoring and Diagnostics
Artificial Intelligence in All Aspects of Care Related to Remote Patient Monitoring
September 23, 2023 | 10:45 AM (PST) - 11:45 AM (PST)
No relevant financial relationships to disclose.